US FDA’s New Generics Chief: We Need More Flexibility For Complex Products

 
• By Derrick Gingery

Iilun Murphy said Hatch-Waxman was written with immediate-release oral drugs in mind, not the complex generics becoming more popular today. The agency is evaluating the issue.

generic drugs
Iilun Murphy became the permanent Office of Generic Drugs director in June. • Source: Shutterstock

More from Generics

More from Biosimilars & Generics